Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Victoria's Secret & Co — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Victoria's Secret & Co trades at $88 (market cap $7.05B). The key difference: Victoria's Secret & Co is the larger of the two by market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| ORKA | VSXY | |
|---|---|---|
Market Cap | $5.08B | $7.05B |
Volume | 685,276 | 1,022,828 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $99.97 |
52-Week Low | $26.19 | $30.19 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $4.21B | $9.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $88.82, up 0.26% today, with strong technical momentum showing bullish moving averages and key support at $87. The company demonstrates improving fundamentals with three consecutive quarterly earnings beats and a robust 45.27% ROE, though net margins remain modest at 5.47%. Recent news highlights brand momentum through fashion show expansions and omnichannel growth strategies, with the stock surging 6.5% on September 28, 2026.
VSXY presents a mixed outlook with accelerating growth projections for 2026 but faces valuation concerns at a P/E of 19.83. Analyst consensus leans bullish with 60% buy ratings and a $86.80 price target, though the current price exceeds this target. Key risks include rich valuation, rising costs, and competitive pressures in retail apparel, while institutional accumulation and strong cash flow projections for 2026 provide support for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
